|
[
]
|
Rule
13d-1(b)
|
|
[X]
|
Rule
13d-1(c)
|
|
[
]
|
Rule
13d-1(d)
|
|
CUSIP
No. 449575-109
|
||||
|
1.
|
Names
of Reporting Persons.
I.R.S.
Identification Nos. of above persons (entities only).
Pharmachem
Laboratories, Inc.
221-625-213
|
|||
|
2.
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
|||
|
(a)
o
|
|
|||
|
(b)
o
|
|
|||
|
3.
|
SEC
Use Only
|
|||
|
4.
|
Citizenship
or Place of Organization
New
Jersey
|
|||
|
Number
of
Shares
Beneficially
Owned
by
Each
Reporting
Person
With
|
||||
|
5.
|
Sole
Voting Power
1,500,000
|
|||
|
6.
|
Shared
Voting Power
0
|
|||
|
7.
|
Sole
Dispositive Power.
1,500,000
|
|||
|
8.
|
Shared
Dispositive Power
0
|
|||
|
9.
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
1,500,000
|
|||
|
10.
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
|||
|
11.
|
Percent
of Class Represented by Amount in Row (9)
10.1
|
|||
|
12.
|
Type
of Reporting Person (See Instructions)
CO
|
|||
|
CUSIP
No. 449575-109
|
|
Item
1.
|
|||
|
(a)
|
Name
of Issuer:
IGI,
Inc.
|
||
|
(b)
|
Address
of Issuer's Principal Executive Offices:
105
Lincoln Avenue
Buena,
NJ 08310
|
||
|
Item
2.
|
|||
|
(a)
|
Name
of Person Filing:
Pharmachem
Laboratories, Inc.
|
||
|
(b)
|
Address
of Principal Business Office or, if none, Residence
265
Harrison Avenue
Kearny,
NJ 07032
|
||
|
(c)
|
Citizenship
New
Jersey
|
||
|
(d)
|
Title
of Class of Securities
Common
Stock
|
||
|
(e)
|
CUSIP
Number
449579-109
|
||
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
check whether the person filing is a:
|
||
|
(a)
|
[
]
|
Broker
or dealer registered under section 15 of the Act (15 U.S.C.
78o).
|
|
|
(b)
|
[
]
|
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).
|
|
|
(c)
|
[
]
|
Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C.
78c).
|
|
|
(d)
|
[
]
|
Investment
company registered under section 8 of the Investment Company Act
of 1940
(15 U.S.C 80a-8).
|
|
|
(e)
|
[
]
|
An
investment adviser in accordance with
§240.13d-1(b)(1)(ii)(E);
|
|
|
(f)
|
[
]
|
An
employee benefit plan or endowment fund in accordance with
§240.13d-1(b)(1)(ii)(F);
|
|
|
(g)
|
[
]
|
A
parent holding company or control person in accordance with §
240.13d-1(b)(1)(ii)(G);
|
|
|
(h)
|
[
]
|
A
savings associations as defined in Section 3(b) of the Federal Deposit
Insurance Act (12 U.S.C. 1813);
|
|
|
(i)
|
[
]
|
A
church plan that is excluded from the definition of an investment
company
under section 3(c)(14) of the Investment Company Act of 1940 (15
U.S.C.
80a-3);
|
|
|
(j)
|
[
]
|
Group,
in accordance with
§240.13d-1(b)(1)(ii)(J).
|
|
|
CUSIP
No. 449575-109
|
|
Item
4.
|
Ownership.
|
||
|
Provide
the following information regarding the aggregate number and percentage
of
the class of securities of the issuer identified in Item 1.
|
|||
|
(a)
|
Amount
beneficially owned:
1,500,000
|
||
|
(b)
|
Percent
of class:
10.1
|
||
|
(c)
|
Number
of shares as to which the person has:
|
||
|
(i)
|
Sole
power to vote or to direct the vote
1,500,000
|
||
|
(ii)
|
Shared
power to vote or to direct the vote
0
|
||
|
(iii)
|
Sole
power to dispose or to direct the disposition of
1,500,000
|
||
|
(iv)
|
Shared
power to dispose or to direct the disposition of
0
|
||
|
Item
5.
|
Ownership
of Five Percent or Less of a Class
|
||
|
Not
Applicable
|
|||
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another
Person.
|
||
|
Not
Applicable
|
|||
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security
Being
Reported on By the Parent Holding Company or Control
Person.
|
||
|
Not
Applicable
|
|||
|
Item
8.
|
Identification
and Classification of Members of the Group
|
||
|
Not
Applicable
|
|||
|
Item
9.
|
Notice
of Dissolution of Group
|
||
|
Not
Applicable
|
|||
|
Item
10.
|
Certification
|
||
|
(a)
|
Not
Applicable
|
||
|
(b)
|
By
signing below I certify that, to the best of my knowledge and belief,
the
securities referred to above were not acquired and are not held for
the
purpose of or with the effect of changing or influencing the control
of
the issuer of the securities and were not acquired and are not held
in
connection with or as a participant in any transaction having that
purpose
or effect.
|
||
|
CUSIP
No. 449575-109
|
|
Pharmachem
Laboratories, Inc.
May
10, 2007
Date
By:
/s/
Andrea
Bauer
Signature
|
|
Attention:
|
Intentional
misstatements or omissions of fact constitute Federal criminal violations
(See
18 U.S.C. 1001)
|